We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$24.1B
AUM Growth
-$195M
Cap. Flow
-$1.62B
Cap. Flow %
-6.71%
Top 10 Hldgs %
6.41%
Holding
1,737
New
114
Increased
913
Reduced
582
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 17.81%
2 Industrials 13.97%
3 Technology 13.12%
4 Consumer Discretionary 10.66%
5 Healthcare 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHM icon
1601
Autohome
ATHM
$2.65B
$21K ﹤0.01%
604
DXCM icon
1602
DexCom
DXCM
$32.9B
$21K ﹤0.01%
1,036
HTHT icon
1603
Huazhu Hotels Group
HTHT
$13.1B
$21K ﹤0.01%
+2,708
New +$19.6K
NWS icon
1604
News Corp Class B
NWS
$17.4B
$21K ﹤0.01%
+1,469
New +$21.1K
XLE icon
1605
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$21K ﹤0.01%
696
+400
+135% +$13.2K
TRVN
1606
DELISTED
Trevena, Inc.
TRVN
$21K ﹤0.01%
3
FLXN
1607
DELISTED
Flexion Therapeutics, Inc.
FLXN
$21K ﹤0.01%
1,096
+62
+6% +$1.08K
ACGN
1608
DELISTED
Aceragen Inc
ACGN
$20K ﹤0.01%
47
+3
+7% +$1.34K
ADMS
1609
DELISTED
Adamas Pharmaceuticals
ADMS
$20K ﹤0.01%
697
+37
+6% +$623
ACFC
1610
DELISTED
Atlantic Coast Financial Corporation
ACFC
$20K ﹤0.01%
3,362
CLDX icon
1611
Celldex Therapeutics
CLDX
$3.04B
$19K ﹤0.01%
82
+4
+5% +$872
XNCR icon
1612
Xencor
XNCR
$1.48B
$19K ﹤0.01%
1,306
+72
+6% +$968
AMPH icon
1613
Amphastar Pharmaceuticals
AMPH
$891M
$18K ﹤0.01%
1,249
+67
+6% +$885
CRIS icon
1614
Curis
CRIS
$9.12M
$18K ﹤0.01%
3
QURE icon
1615
uniQure
QURE
$3.03B
$18K ﹤0.01%
1,060
+57
+6% +$1.06K
GNMX
1616
DELISTED
Aevi Genomic Medicine Inc
GNMX
$18K ﹤0.01%
2,927
+162
+6% +$1.1K
DO
1617
DELISTED
Diamond Offshore Drilling
DO
$18K ﹤0.01%
+868
New +$18.3K
ARWR icon
1618
Arrowhead Research
ARWR
$12.5B
$17K ﹤0.01%
2,816
+274
+11% +$1.55K
TGTX icon
1619
TG Therapeutics
TGTX
$7.15B
$16K ﹤0.01%
1,353
+75
+6% +$947
UE icon
1620
Urban Edge Properties
UE
$2.83B
$15K ﹤0.01%
637
ACAD icon
1621
Acadia Pharmaceuticals
ACAD
$4.47B
$14K ﹤0.01%
402
+23
+6% +$810
BLUE
1622
DELISTED
bluebird bio
BLUE
$14K ﹤0.01%
+16
New +$16K
LCNB icon
1623
LCNB Corp
LCNB
$284M
$14K ﹤0.01%
865
CPHD
1624
DELISTED
Cepheid Inc
CPHD
$14K ﹤0.01%
385
+23
+6% +$817
AGEN
1625
Agenus
AGEN
$335M
$13K ﹤0.01%
147
+8
+6% +$732

Similar funds

Victory Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Victory Capital Management held 1,737 positions worth $24.1B, down 0.81% from $24.3B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Victory Capital Management withdrew a net $1.62B in Q4 2015, closing 87 positions and reducing 582 holdings. Its most notable exit was HUBBELL INC CL-B, an estimated $87.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Hubbell worth $111M.

  • Victory Capital Management's largest Q4 2015 buy was Hubbell: 1,099,403 shares worth $111M.
  • Victory Capital Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2015, an estimated $97.6M increase.
  • Victory Capital Management's biggest Q4 2015 reduction was Lincoln National, cutting an estimated $135M.
  • Victory Capital Management fully exited HUBBELL INC CL-B in Q4 2015, selling an estimated $87.1M.
  • Victory Capital Management's ten largest holdings make up 6.4% of its $24.1B portfolio in Q4 2015.
  • Victory Capital Management opened 114 new positions and closed 87 in Q4 2015.
  • Victory Capital Management's portfolio value fell 0.81% quarter-over-quarter to $24.1B.

Based on Victory Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.